{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:44:37Z","timestamp":1776231877610,"version":"3.50.1"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Waldenstr\u00f6m macroglobulinemia (WM) is a rare CD20-positive B-cell non-Hodgkin lymphoma. It is characterized by lymphoplasmacytic infiltration in the bone marrow and abnormal monoclonal IgM secretion. WM complicated by renal amyloidosis is uncommon but associated with rapid progression of organ damage. Accurate identification of pathogenic factors and individualized treatments are essential to improve prognosis. This paper reports the case of a 75-year-old female who initially presented with facial edema and bilateral lower-extremity edema lasting 2\u202fdays. Additional symptoms included foamy urine, frequent urination, and urgency. Laboratory tests revealed significant proteinuria (24-h urinary protein, 6.11\u202fg), hypoalbuminemia (serum albumin, 20.07\u202fg\/L), and impaired renal function (serum creatinine, 129.90\u202f\u03bcmol\/L; eGFR, 45.2\u202fmL\/min\/1.73\u202fm\n                    <jats:sup>2<\/jats:sup>\n                    ). Immunofixation electrophoresis detected monoclonal IgM-\n                    <jats:italic>\u03bb<\/jats:italic>\n                    immunoglobulin in both serum and urine. Bone marrow biopsy demonstrated clonal lymphoplasmacytic infiltration (32%), and genetic testing revealed a positive MYD88-L265P mutation (mutation frequency, 28.5%). Renal biopsy indicated diffuse deposition of\n                    <jats:italic>\u03bb<\/jats:italic>\n                    light chains predominantly in the glomerular mesangium. Ultrastructural examination revealed amyloid fibrils, confirming the diagnosis of AL\n                    <jats:italic>\u03bb<\/jats:italic>\n                    \u202f\u2212\u202ftype amyloid nephropathy. Chemotherapy with rituximab, cyclophosphamide, and dexamethasone (RCD regimen), combined with symptomatic supportive therapy, resulted in temporary improvement of clinical symptoms and laboratory parameters. However, the disease progressed rapidly. The patient died on Jan 28, 2024, approximately 3\u202fmonths after discharge, due to multiple organ failure involving cardiac, renal, and respiratory dysfunction. Based on relevant literature and the Chinese Expert Consensus on Diagnosis and Treatment of Lymphoplasmacytic Lymphoma (LPL)\/WM (2022 Edition) [Abstract 3], this paper discusses diagnostic criteria, differentiation of pathogenic components, treatment strategies, and prognostic factors. These findings may provide clinical guidance for similar rare cases.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2026.1806896","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:45:42Z","timestamp":1776228342000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Waldenstr\u00f6m macroglobulinemia complicated with AL \u03bb\u202f\u2212\u202ftype amyloid nephropathy: a case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuan","family":"Ma","sequence":"first","affiliation":[{"name":"Gansu University of Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taotao","family":"Li","sequence":"additional","affiliation":[{"name":"Gansu University of Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Gansu Provincial Hospital","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.pathol.2019.09.009","article-title":"Lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinaemia: clinicopathological features and differential diagnosis","volume":"52","author":"Wang","year":"2020","journal-title":"Pathology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.hoc.2019.03.004","article-title":"Lymphoplasmacytic lymphoma and marginal zone lymphoma","volume":"33","author":"Ju\u00e1rez-Salcedo","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3760\/cma.j.issn.0253-2727.2022.08.002","article-title":"Chinese guideline for diagnosis and treatment of lymphoplasmacytic lymphoma\/Walderstr\u00f6m macroglobulinemia (2022)","volume":"43","year":"2022","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/17474086.2023.2270779","article-title":"New developments in the diagnosis and characterization of Waldenstr\u00f6m's macroglobulinemia","volume":"16","author":"Garc\u00eda-Sanz","year":"2023","journal-title":"Expert Rev Hematol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1200\/JCO.19.02314","article-title":"Genomic landscape of Waldenstr\u00f6m macroglobulinemia and its impact on treatment strategies","volume":"38","author":"Treon","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1080\/10428194.2025.2512392","article-title":"Not just amyloidosis: the spectrum of Waldenstrom's macroglobulinemia-associated renal disease","volume":"66","author":"Giachetti","year":"2025","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"102715","DOI":"10.1016\/j.ctrv.2024.102715","article-title":"How to manage Waldenstr\u00f6m's macroglobulinemia in 2024","volume":"125","author":"Grunenberg","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1200\/JCO.21.00838","article-title":"Ibrutinib plus rituximab versus placebo plus rituximab for Waldenstr\u00f6m's macroglobulinemia: final analysis from the randomized phase III iNNOVATE study","volume":"40","author":"Buske","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10637-025-01513-y","article-title":"From development to clinical success: the journey of established and next-generation BTK inhibitors","volume":"43","author":"Gupta","year":"2025","journal-title":"Investig New Drugs"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.hoc.2018.05.009","article-title":"Alkylating agents in the treatment of Waldenstr\u00f6m macroglobulinemia","volume":"32","author":"Buske","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41375-022-01732-9","article-title":"Managing Waldenstr\u00f6m\u2019s macroglobulinemia with BTK inhibitors","volume":"37","author":"Buske","year":"2023","journal-title":"Leukemia"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e240001","DOI":"10.6004\/jnccn.2024.0001","article-title":"Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphoma, version 2.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Kumar","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"12661","DOI":"10.3390\/ijms232012662","article-title":"Noninvasive diagnostics of renal amyloidosis: current state and perspectives","volume":"23","author":"Fedotov","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000533195","article-title":"Kidney biopsy corner: amyloidosis","volume":"3","author":"Biederman","year":"2023","journal-title":"Glomerular Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry\u2013based proteomic analysis in clinical biopsy specimens","volume":"114","author":"Vrana","year":"2009","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e24624","DOI":"10.7759\/cureus.24624","article-title":"Diagnosing and managing clinically silent lupus nephritis and anti-neutrophil cytoplasmic antibody-associated vasculitis overlap syndrome: a clinical challange","volume":"14","author":"Ashraf","year":"2022","journal-title":"Cureus"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1806896\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:45:55Z","timestamp":1776228355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1806896\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":18,"alternative-id":["10.3389\/fmed.2026.1806896"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1806896","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"1806896"}}